Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Loss and Comprehensive Loss

v3.8.0.1
Consolidated Statements of Loss and Comprehensive Loss - USD ($)
$ in Thousands
8 Months Ended 12 Months Ended
Dec. 31, 2015
Dec. 31, 2017
Dec. 31, 2016
EXPENSES      
Research and development $ 107 $ 3,101 $ 286
General and administrative 1,116 3,531 1,428
Total operating expenses 1,223 6,632 1,714
OTHER INCOME (EXPENSE)      
Interest income   21  
Bargain purchase gain [note 2]   1,272  
Contingent value rights recovery [note 2]   200  
Gain on warrants   150  
Loss on disposition of intangible asset [note 5]   (8,610)  
Other expenses (12) (35) (24)
Total other income (12) (7,002) (24)
Net loss before income taxes (1,235) (13,634) (1,738)
Recovery of deferred income taxes [note 5] 407 3,051 504
Net Loss (828) (10,583) (1,234)
OTHER COMPREHENSIVE INCOME      
Net unrealized gain on foreign exchange 1   4
Total other comprehensive income (loss) 1   4
Comprehensive loss $ (827) $ (10,583) $ (1,230)
Basic and diluted net loss per common share [note 12 [g]] $ (39.00) $ (2.21) $ (58.13)
Shares used in computation of basic and diluted net loss per common share [note 12 [g]] 21,230 4,794,421 21,230